News
Las acciones de NeuroDerm suben un 70% en Wall Street tras anunciar...
www.europapress.es
La cotización de las acciones de la farmacéutica NeuroDerm se ha visto catapultada más de un 70% tras la...
NeuroDerm Announces Positive Results of a Phase II Study of ND
www.finanznachrichten.de
NESS ZIONA, Israel, November 9, PRNewswire/ -- NeuroDerm, Ltd. announced today the results of a Phase I/II safety and pharmacokinetic trial of ND0611,...
History of Changes for Study: NCT
clinicaltrials.gov
Central Contact Person: Sheila Oren, MD Telephone: + Central Contact Backup: Irit Kopelov Telephone: +
Israeli NeuroDerm Announces Success in New Parkinson's ...jewishbusinessnews.com › › israeli-n...
jewishbusinessnews.com
... that often have debilitating ramifications for patients, ” said Sheila Oren, M.D., NeuroDerm Vice President of Clinical and Regulatory Affairs, ...
sortiert nach Relevanz / Datum